Cargando…

Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus

OBJECTIVE: This study was undertaken to validate the accuracy of the Epidemiology‐Based Mortality Score in Status Epilepticus (EMSE) in predicting the risk of death at 30 days in a large cohort of patients with status epilepticus (SE) using a machine learning system. METHODS: We included consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Brigo, Francesco, Turcato, Gianni, Lattanzi, Simona, Orlandi, Niccolò, Turchi, Giulia, Zaboli, Arian, Giovannini, Giada, Meletti, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804228/
https://www.ncbi.nlm.nih.gov/pubmed/35869796
http://dx.doi.org/10.1111/epi.17372
_version_ 1784862058518413312
author Brigo, Francesco
Turcato, Gianni
Lattanzi, Simona
Orlandi, Niccolò
Turchi, Giulia
Zaboli, Arian
Giovannini, Giada
Meletti, Stefano
author_facet Brigo, Francesco
Turcato, Gianni
Lattanzi, Simona
Orlandi, Niccolò
Turchi, Giulia
Zaboli, Arian
Giovannini, Giada
Meletti, Stefano
author_sort Brigo, Francesco
collection PubMed
description OBJECTIVE: This study was undertaken to validate the accuracy of the Epidemiology‐Based Mortality Score in Status Epilepticus (EMSE) in predicting the risk of death at 30 days in a large cohort of patients with status epilepticus (SE) using a machine learning system. METHODS: We included consecutive patients with SE admitted from 2013 to 2021 at Modena Academic Hospital. A decision tree analysis was performed using the 30‐day mortality as a dependent variable and the EMSE predictors as input variables. We evaluated the accuracy of EMSE in predicting 30‐day mortality using the area under the receiver operating characteristic curve (AUC ROC), with 95% confidence interval (CI). We performed a subgroup analysis on nonhypoxic SE. RESULTS: A total of 698 patients with SE were included, with a 30‐day mortality of 28.9% (202/698). The mean EMSE value in the entire population was 57.1 (SD = 36.3); it was lower in surviving compared to deceased patients (47.1, SD = 31.7 vs. 81.9, SD = 34.8; p < .001). The EMSE was accurate in predicting 30‐day mortality, with an AUC ROC of .782 (95% CI = .747–.816). Etiology was the most relevant predictor, followed by age, electroencephalogram (EEG), and EMSE comorbidity group B. The decision tree analysis using EMSE variables correctly predicted the risk of mortality in 77.9% of cases; the prediction was accurate in 85.7% of surviving and in 58.9% of deceased patients within 30 days after SE. In nonhypoxic SE, the most relevant predictor was age, followed by EEG, and EMSE comorbidity group B; the prediction was correct in 78.9% of all cases (89.6% in survivors and 46.1% in nonsurvivors). SIGNIFICANCE: This validation study using a machine learning analysis shows that the EMSE is a valuable prognostic tool, and appears particularly accurate and effective in identifying patients with 30‐day survival, whereas its performance in predicting 30‐day mortality is lower and needs to be further improved.
format Online
Article
Text
id pubmed-9804228
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98042282023-01-03 Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus Brigo, Francesco Turcato, Gianni Lattanzi, Simona Orlandi, Niccolò Turchi, Giulia Zaboli, Arian Giovannini, Giada Meletti, Stefano Epilepsia Research Article OBJECTIVE: This study was undertaken to validate the accuracy of the Epidemiology‐Based Mortality Score in Status Epilepticus (EMSE) in predicting the risk of death at 30 days in a large cohort of patients with status epilepticus (SE) using a machine learning system. METHODS: We included consecutive patients with SE admitted from 2013 to 2021 at Modena Academic Hospital. A decision tree analysis was performed using the 30‐day mortality as a dependent variable and the EMSE predictors as input variables. We evaluated the accuracy of EMSE in predicting 30‐day mortality using the area under the receiver operating characteristic curve (AUC ROC), with 95% confidence interval (CI). We performed a subgroup analysis on nonhypoxic SE. RESULTS: A total of 698 patients with SE were included, with a 30‐day mortality of 28.9% (202/698). The mean EMSE value in the entire population was 57.1 (SD = 36.3); it was lower in surviving compared to deceased patients (47.1, SD = 31.7 vs. 81.9, SD = 34.8; p < .001). The EMSE was accurate in predicting 30‐day mortality, with an AUC ROC of .782 (95% CI = .747–.816). Etiology was the most relevant predictor, followed by age, electroencephalogram (EEG), and EMSE comorbidity group B. The decision tree analysis using EMSE variables correctly predicted the risk of mortality in 77.9% of cases; the prediction was accurate in 85.7% of surviving and in 58.9% of deceased patients within 30 days after SE. In nonhypoxic SE, the most relevant predictor was age, followed by EEG, and EMSE comorbidity group B; the prediction was correct in 78.9% of all cases (89.6% in survivors and 46.1% in nonsurvivors). SIGNIFICANCE: This validation study using a machine learning analysis shows that the EMSE is a valuable prognostic tool, and appears particularly accurate and effective in identifying patients with 30‐day survival, whereas its performance in predicting 30‐day mortality is lower and needs to be further improved. John Wiley and Sons Inc. 2022-08-23 2022-10 /pmc/articles/PMC9804228/ /pubmed/35869796 http://dx.doi.org/10.1111/epi.17372 Text en © 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Article
Brigo, Francesco
Turcato, Gianni
Lattanzi, Simona
Orlandi, Niccolò
Turchi, Giulia
Zaboli, Arian
Giovannini, Giada
Meletti, Stefano
Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus
title Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus
title_full Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus
title_fullStr Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus
title_full_unstemmed Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus
title_short Machine learning validation through decision tree analysis of the Epidemiology‐Based Mortality Score in Status Epilepticus
title_sort machine learning validation through decision tree analysis of the epidemiology‐based mortality score in status epilepticus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804228/
https://www.ncbi.nlm.nih.gov/pubmed/35869796
http://dx.doi.org/10.1111/epi.17372
work_keys_str_mv AT brigofrancesco machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus
AT turcatogianni machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus
AT lattanzisimona machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus
AT orlandiniccolo machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus
AT turchigiulia machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus
AT zaboliarian machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus
AT giovanninigiada machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus
AT melettistefano machinelearningvalidationthroughdecisiontreeanalysisoftheepidemiologybasedmortalityscoreinstatusepilepticus